Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PharmacoEconomics 2018-04, Vol.36 (4), p.507-507
Hauptverfasser: Tikhonova, Irina A., Jones-Hughes, Tracey, Dunham, James, Warren, Fiona C., Robinson, Sophie, Stephens, Peter, Hoyle, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Correction
Health Administration
Health Economics
Medicine
Medicine & Public Health
Pharmacoeconomics and Health Outcomes
Public Health
Quality of Life Research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Page 41, Column 1, Section 3.1, paragraph 2, 1st sentence which
ISSN:1170-7690
1179-2027
DOI:10.1007/s40273-018-0635-4